LTZ Therapeutics

LTZ Therapeutics is a biotech company in Shenzhen, China, founded in 2022. It has raised $68.0M across 4 rounds, most recently a $38.0M Series B in April 2026.

Lift to Zenith with Novel Myeloid Engager Therapeutics

Headquarters
Shenzhen
Employees
11–50
Founded
2022
Business Model
B2B
Total Funding
$68.0M
Last Round
$38.0M Series BApr 2026
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 9 investors for this company. The full record is or through the API.

About

LTZ Therapeutics is a clinical-stage, immunotherapy-focused biotechnology company pioneering a novel Myeloid Engager Platform to treat oncology and autoimmune diseases. Founded in 2022 and headquartered in Redwood City, California with operations in Shenzhen, China, the company applies reverse translational science to develop Universal Myeloid Cell Engager (U-MCE)-based therapies targeting unmet clinical needs in cancer immunology.

Summary

It lists 11–50 employees. It has raised $68.0M in total across 4 rounds, most recently a $38.0M Series B round in Apr 2026. Investors include Hillhouse Capital, Qiming VP and Lanchi Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BApr 2026
$38.0M

Sign up to see all 4 events

Funding: Pre-Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

LTZ Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/ltz-therapeutics"><img src="https://indexed.vc/api/badge/company/ltz-therapeutics" alt="LTZ Therapeutics on Indexed.vc" width="260" height="76" /></a>